170 related articles for article (PubMed ID: 8343986)
1. Cholinesterases as scavengers for organophosphorus compounds: protection of primate performance against soman toxicity.
Doctor BP; Blick DW; Caranto G; Castro CA; Gentry MK; Larrison R; Maxwell DM; Murphy MR; Schutz M; Waibel K
Chem Biol Interact; 1993 Jun; 87(1-3):285-93. PubMed ID: 8343986
[TBL] [Abstract][Full Text] [Related]
2. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes.
Caranto GR; Waibel KH; Asher JM; Larrison RW; Brecht KM; Schutz MB; Raveh L; Ashani Y; Wolfe AD; Maxwell DM
Biochem Pharmacol; 1994 Jan; 47(2):347-57. PubMed ID: 8304979
[TBL] [Abstract][Full Text] [Related]
3. Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase.
Maxwell DM; Castro CA; De La Hoz DM; Gentry MK; Gold MB; Solana RP; Wolfe AD; Doctor BP
Toxicol Appl Pharmacol; 1992 Jul; 115(1):44-9. PubMed ID: 1631892
[TBL] [Abstract][Full Text] [Related]
4. Use of cholinesterases as pretreatment drugs for the protection of rhesus monkeys against soman toxicity.
Wolfe AD; Blick DW; Murphy MR; Miller SA; Gentry MK; Hartgraves SL; Doctor BP
Toxicol Appl Pharmacol; 1992 Dec; 117(2):189-93. PubMed ID: 1471150
[TBL] [Abstract][Full Text] [Related]
5. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
6. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
7. Acetylcholinesterase prophylaxis against organophosphate toxicity.
Wolfe AD; Rush RS; Doctor BP; Koplovitz I; Jones D
Fundam Appl Toxicol; 1987 Aug; 9(2):266-70. PubMed ID: 3653568
[TBL] [Abstract][Full Text] [Related]
8. Mutant acetylcholinesterases as potential detoxification agents for organophosphate poisoning.
Saxena A; Maxwell DM; Quinn DM; Radić Z; Taylor P; Doctor BP
Biochem Pharmacol; 1997 Jul; 54(2):269-74. PubMed ID: 9271331
[TBL] [Abstract][Full Text] [Related]
9. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.
Broomfield CA; Maxwell DM; Solana RP; Castro CA; Finger AV; Lenz DE
J Pharmacol Exp Ther; 1991 Nov; 259(2):633-8. PubMed ID: 1941611
[TBL] [Abstract][Full Text] [Related]
10. Protection against both lethal and behavioral effects of soman.
Harris LW; McDonough JH; Stitcher DL; Lennox WJ
Drug Chem Toxicol; 1984; 7(6):605-24. PubMed ID: 6534735
[TBL] [Abstract][Full Text] [Related]
11. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
12. Acute behavioral toxicity of pyridostigmine or soman in primates.
Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
[TBL] [Abstract][Full Text] [Related]
13. Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents.
Albuquerque EX; Pereira EF; Aracava Y; Fawcett WP; Oliveira M; Randall WR; Hamilton TA; Kan RK; Romano JA; Adler M
Proc Natl Acad Sci U S A; 2006 Aug; 103(35):13220-5. PubMed ID: 16914529
[TBL] [Abstract][Full Text] [Related]
14. Examination of the role of central cholinergic mechanisms in the therapeutic effects of HI-6 in organophosphate poisoning.
Lundy PM; Shih TM
J Neurochem; 1983 May; 40(5):1321-8. PubMed ID: 6834063
[TBL] [Abstract][Full Text] [Related]
15. The protection of primates against soman poisoning by pretreatment with pyridostigmine.
Dirnhuber P; French MC; Green DM; Leadbeater L; Stratton JA
J Pharm Pharmacol; 1979 May; 31(5):295-9. PubMed ID: 37298
[TBL] [Abstract][Full Text] [Related]
16. HI-6: reactivation of central and peripheral acetylcholinesterase following inhibition by soman, sarin and tabun in vivo in the rat.
Clement JG
Biochem Pharmacol; 1982 Apr; 31(7):1283-7. PubMed ID: 7092921
[TBL] [Abstract][Full Text] [Related]
17. Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkeys.
Castro CA; Larsen T; Finger AV; Solana RP; McMaster SB
Pharmacol Biochem Behav; 1992 Jan; 41(1):159-64. PubMed ID: 1539066
[TBL] [Abstract][Full Text] [Related]
18. Acute behavioural effects of the organophosphates sarin and soman in rats.
Nieminen SA; Lecklin A; Heikkinen O; Ylitalo P
Pharmacol Toxicol; 1990 Jul; 67(1):36-40. PubMed ID: 2395814
[TBL] [Abstract][Full Text] [Related]
19. Behavioral toxicity of anticholinesterases in primates: effects of daily repeated soman exposure.
Blick DW; Weathersby FR; Brown GC; Murphy MR
Pharmacol Biochem Behav; 1994 Jul; 48(3):643-9. PubMed ID: 7938117
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman.
de Jong LP; Wolring GZ
Biochem Pharmacol; 1984 Apr; 33(7):1119-25. PubMed ID: 6712722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
